Tess Kirilenko

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies”.

Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies

Scientific Reports(2020)10.1038/s41598-020-64500-8

N/A

0DataRank · unranked

11 citations

Tess Kirilenko, Quratulain Qureshi, Naiomi Lu, Nino Trattnig, Paul Kosma +2 more

Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.24.962233

N/A

0DataRank · unranked

3 citations

Tess Kirilenko, Quratulain Qureshi, Naiomi Lu, Nino Trattnig, Paul Kosma +2 more

A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies

Scientific Reports(2021)10.1038/s41598-021-84116-w

N/A

0DataRank · unranked

3 citations

Tess Kirilenko, Nino Trattnig, Yiqiu Yang, Matteo Cattin, Paul Kosma +2 more

A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies

Research Square(2021)10.21203/rs.3.rs-140631/v2

N/A

0DataRank · unranked

0 citations

Tess Kirilenko, Nino Trattnig, Yiqiu Yang, Matteo Cattin, Paul Kosma +2 more

A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies

Research Square(2021)10.21203/rs.3.rs-140631/v1

N/A

0DataRank · unranked

0 citations

Tess Kirilenko, Nino Trattnig, Yiqiu Yang, Matteo Cattin, Paul Kosma +2 more